Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

The ability of a host to curb a viral infection is heavily reliant on the effectiveness of an initial antiviral innate immune response, resulting in the upregulation of interferon (IFN) and, subsequently, IFN-stimulated genes (ISGs). ISGs serve to mount an antiviral state within a host cell, and alt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of innate immunity 2018-01, Vol.10 (2), p.85-93
Hauptverfasser: Crosse, Keaton M., Monson, Ebony A., Beard, Michael R., Helbig, Karla J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 93
container_issue 2
container_start_page 85
container_title Journal of innate immunity
container_volume 10
creator Crosse, Keaton M.
Monson, Ebony A.
Beard, Michael R.
Helbig, Karla J.
description The ability of a host to curb a viral infection is heavily reliant on the effectiveness of an initial antiviral innate immune response, resulting in the upregulation of interferon (IFN) and, subsequently, IFN-stimulated genes (ISGs). ISGs serve to mount an antiviral state within a host cell, and although the specific antiviral function of a number of ISGs has been characterized, the function of many of these ISGs remains to be determined. Recent research has uncovered a novel role for a handful of ISGs, some of them directly induced by IFN regulatory factor 3 in the absence of IFN itself. These ISGs, most with potent antiviral activity, are also able to augment varying arms of the innate immune response to viral infection, thereby strengthening this response. This new understanding of the role of ISGs may, in turn, help the recent advancement of novel therapeutics aiming to augment innate signaling pathways in an attempt to control viral infection and pathogenesis.
doi_str_mv 10.1159/000484258
format Article
fullrecord <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_karger_primary_484258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1970629843</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-e6d34148543fce0f4fcea6cf8fa82194bd90e85d22fd3c041b3edba093b7902d3</originalsourceid><addsrcrecordid>eNpVkMFLwzAUxoMoTqcH7yI96qGapGmWXIQx5hxMPEzBW0jbly3apjNpB_73VjaLXt578H7vfR8fQhcE3xKSyjuMMROMpuIAnRDOaSwIFYf9TN4G6DSEd4w5Y3J0jAZUEsFHRJygp7lrwBvwtYuXja3aUjdQRDNwECIdoqlba5eDD1FtorFr7NZ6XUZz5zoumldV6yBa2pXTpXWrM3RkdBngfN-H6PVh-jJ5jBfPs_lkvIhzxmkTAy8SRphIWWJywIZ1VfPcCKMFJZJlhcQg0oJSUyQ5ZiRLoMg0lkk2kpgWyRDd7_5u2qyCIgfXdK7UxttK-y9Va6v-b5xdq1W9VankEneyQ3S9f-DrzxZCoyobcihL7aBugyJyhDmVgiUderNDc1-H4MH0MgSrn_hVH3_HXv311ZO_eXfA5Q740H4Fvgf299_r14p9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1970629843</pqid></control><display><type>article</type><title>Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Crosse, Keaton M. ; Monson, Ebony A. ; Beard, Michael R. ; Helbig, Karla J.</creator><creatorcontrib>Crosse, Keaton M. ; Monson, Ebony A. ; Beard, Michael R. ; Helbig, Karla J.</creatorcontrib><description>The ability of a host to curb a viral infection is heavily reliant on the effectiveness of an initial antiviral innate immune response, resulting in the upregulation of interferon (IFN) and, subsequently, IFN-stimulated genes (ISGs). ISGs serve to mount an antiviral state within a host cell, and although the specific antiviral function of a number of ISGs has been characterized, the function of many of these ISGs remains to be determined. Recent research has uncovered a novel role for a handful of ISGs, some of them directly induced by IFN regulatory factor 3 in the absence of IFN itself. These ISGs, most with potent antiviral activity, are also able to augment varying arms of the innate immune response to viral infection, thereby strengthening this response. This new understanding of the role of ISGs may, in turn, help the recent advancement of novel therapeutics aiming to augment innate signaling pathways in an attempt to control viral infection and pathogenesis.</description><identifier>ISSN: 1662-811X</identifier><identifier>EISSN: 1662-8128</identifier><identifier>DOI: 10.1159/000484258</identifier><identifier>PMID: 29186718</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Review</subject><ispartof>Journal of innate immunity, 2018-01, Vol.10 (2), p.85-93</ispartof><rights>2017 The Author(s) Published by S. Karger AG, Basel</rights><rights>2017 The Author(s) Published by S. Karger AG, Basel.</rights><rights>Copyright © 2017 by S. Karger AG, Basel 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-e6d34148543fce0f4fcea6cf8fa82194bd90e85d22fd3c041b3edba093b7902d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969054/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969054/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29186718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crosse, Keaton M.</creatorcontrib><creatorcontrib>Monson, Ebony A.</creatorcontrib><creatorcontrib>Beard, Michael R.</creatorcontrib><creatorcontrib>Helbig, Karla J.</creatorcontrib><title>Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling</title><title>Journal of innate immunity</title><addtitle>J Innate Immun</addtitle><description>The ability of a host to curb a viral infection is heavily reliant on the effectiveness of an initial antiviral innate immune response, resulting in the upregulation of interferon (IFN) and, subsequently, IFN-stimulated genes (ISGs). ISGs serve to mount an antiviral state within a host cell, and although the specific antiviral function of a number of ISGs has been characterized, the function of many of these ISGs remains to be determined. Recent research has uncovered a novel role for a handful of ISGs, some of them directly induced by IFN regulatory factor 3 in the absence of IFN itself. These ISGs, most with potent antiviral activity, are also able to augment varying arms of the innate immune response to viral infection, thereby strengthening this response. This new understanding of the role of ISGs may, in turn, help the recent advancement of novel therapeutics aiming to augment innate signaling pathways in an attempt to control viral infection and pathogenesis.</description><subject>Review</subject><issn>1662-811X</issn><issn>1662-8128</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><recordid>eNpVkMFLwzAUxoMoTqcH7yI96qGapGmWXIQx5hxMPEzBW0jbly3apjNpB_73VjaLXt578H7vfR8fQhcE3xKSyjuMMROMpuIAnRDOaSwIFYf9TN4G6DSEd4w5Y3J0jAZUEsFHRJygp7lrwBvwtYuXja3aUjdQRDNwECIdoqlba5eDD1FtorFr7NZ6XUZz5zoumldV6yBa2pXTpXWrM3RkdBngfN-H6PVh-jJ5jBfPs_lkvIhzxmkTAy8SRphIWWJywIZ1VfPcCKMFJZJlhcQg0oJSUyQ5ZiRLoMg0lkk2kpgWyRDd7_5u2qyCIgfXdK7UxttK-y9Va6v-b5xdq1W9VankEneyQ3S9f-DrzxZCoyobcihL7aBugyJyhDmVgiUderNDc1-H4MH0MgSrn_hVH3_HXv311ZO_eXfA5Q740H4Fvgf299_r14p9</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Crosse, Keaton M.</creator><creator>Monson, Ebony A.</creator><creator>Beard, Michael R.</creator><creator>Helbig, Karla J.</creator><general>S. Karger AG</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling</title><author>Crosse, Keaton M. ; Monson, Ebony A. ; Beard, Michael R. ; Helbig, Karla J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-e6d34148543fce0f4fcea6cf8fa82194bd90e85d22fd3c041b3edba093b7902d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crosse, Keaton M.</creatorcontrib><creatorcontrib>Monson, Ebony A.</creatorcontrib><creatorcontrib>Beard, Michael R.</creatorcontrib><creatorcontrib>Helbig, Karla J.</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of innate immunity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crosse, Keaton M.</au><au>Monson, Ebony A.</au><au>Beard, Michael R.</au><au>Helbig, Karla J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling</atitle><jtitle>Journal of innate immunity</jtitle><addtitle>J Innate Immun</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>10</volume><issue>2</issue><spage>85</spage><epage>93</epage><pages>85-93</pages><issn>1662-811X</issn><eissn>1662-8128</eissn><abstract>The ability of a host to curb a viral infection is heavily reliant on the effectiveness of an initial antiviral innate immune response, resulting in the upregulation of interferon (IFN) and, subsequently, IFN-stimulated genes (ISGs). ISGs serve to mount an antiviral state within a host cell, and although the specific antiviral function of a number of ISGs has been characterized, the function of many of these ISGs remains to be determined. Recent research has uncovered a novel role for a handful of ISGs, some of them directly induced by IFN regulatory factor 3 in the absence of IFN itself. These ISGs, most with potent antiviral activity, are also able to augment varying arms of the innate immune response to viral infection, thereby strengthening this response. This new understanding of the role of ISGs may, in turn, help the recent advancement of novel therapeutics aiming to augment innate signaling pathways in an attempt to control viral infection and pathogenesis.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>29186718</pmid><doi>10.1159/000484258</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1662-811X
ispartof Journal of innate immunity, 2018-01, Vol.10 (2), p.85-93
issn 1662-811X
1662-8128
language eng
recordid cdi_karger_primary_484258
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Review
title Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A08%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interferon-Stimulated%20Genes%20as%20Enhancers%20of%20Antiviral%20Innate%20Immune%20Signaling&rft.jtitle=Journal%20of%20innate%20immunity&rft.au=Crosse,%20Keaton%20M.&rft.date=2018-01-01&rft.volume=10&rft.issue=2&rft.spage=85&rft.epage=93&rft.pages=85-93&rft.issn=1662-811X&rft.eissn=1662-8128&rft_id=info:doi/10.1159/000484258&rft_dat=%3Cproquest_karge%3E1970629843%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1970629843&rft_id=info:pmid/29186718&rfr_iscdi=true